Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Medullary × Bortezomib × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 89 Neoplasms, Plasma Cell 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid, Acute 6 Immunoglobulin Light-chain Amyloidosis 6 Recurrence 5 Hematologic Neoplasms 4 Waldenstrom Macroglobulinemia 3 Paraproteinemias 3 Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Renal Insufficiency 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Leukemia 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Amyloidosis 2 beta-Thalassemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Sarcoma, Myeloid 1 Plasmacytoma 1 Peripheral Nervous System Diseases 1 Neoplasm, Residual 1

Interventions

selpercatinib 5 vandetanib 4 cabozantinib 3 Magnetic Resonance Spectroscopy 3 pralsetinib 1 fluorodopa F 18 1 fludarabine 1 Sunitinib 1 Standard of Care 1 Specimen Handling 1 Radiofrequency Ablation 1 Practice Guidelines as Topic 1 Pharmacogenomic Testing 1 Nivolumab 1 Laser Therapy 1 Interviews as Topic 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Decision Support Techniques 1 Cyclophosphamide 1 Cryosurgery 1 Cryoelectron Microscopy 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡